XTX Topco’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.88M Buy
4,218
+3,266
+343% +$3.31M 0.07% 417
2025
Q4
$1.02M Sell
952
-2,912
-75% -$2.78M 0.03% 1006
2025
Q3
$2.95M Sell
3,864
-7,716
-67% -$5.74M 0.15% 114
2025
Q2
$9.03M Buy
+11,580
New +$9M 0.37% 20
2024
Q3
Sell
-603
Closed -$546K 2366
2024
Q2
$546K Buy
+603
New +$482K 0.05% 615
2024
Q1
Sell
-1,266
Closed -$738K 2115
2023
Q4
$738K Sell
1,266
-4,965
-80% -$2.9M 0.16% 89
2023
Q3
$3.35M Buy
+6,231
New +$3.21M 0.57% 1
2023
Q1
Sell
-2,471
Closed -$904K 1486
2022
Q4
$904K Buy
+2,471
New +$876K 0.19% 109
2022
Q2
Sell
-844
Closed -$242K 980
2022
Q1
$242K Buy
+844
New +$217K 0.11% 346

Other funds holding LLY

XTX Topco's LLY Position: Q1 2026 in Review

XTX Topco increased its Eli Lilly (LLY) stake by 343% in Q1 2026, buying an estimated $3.31M and bringing the position to 4,218 shares worth $3.88M. The position accounts for 0.07% of the portfolio, ranked #417.

XTX Topco first reported a position in LLY in Q1 2022 and has held it in 9 quarters since. The position peaked at $9.03M in Q2 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • XTX Topco held 4,218 shares of Eli Lilly worth $3.88M as of Q1 2026.
  • XTX Topco bought 3,266 Eli Lilly shares in Q1 2026, an estimated $3.31M.
  • Eli Lilly made up 0.07% of XTX Topco's portfolio in Q1 2026, its #417 holding.
  • XTX Topco first reported a position in Eli Lilly in Q1 2022 and has held it in 9 quarters since.
  • XTX Topco's Eli Lilly position peaked at $9.03M in Q2 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.